Diverse Distribution and Gene Expression on the 21-Gene Recurrence Assay in Breast Cancer Patients with Locoregional Recurrence Versus Distant Metastasis-Reference-Cited by-同舟云学术

Diverse Distribution and Gene Expression on the 21-Gene Recurrence Assay in Breast Cancer Patients with Locoregional Recurrence Versus Distant Metastasis

Published:2021-08 Issue: Volume:Volume 13 Page:6279-6289
ISSN:1179-1322
Container-title:Cancer Management and Research
language:en
Short-container-title:CMAR

Author:

Lu Yujie,Tong Yiwei,Huang Jiahui,Lin Lin,Wu Jiayi,Fei Xiaochun,Chen Xiaosong^ORCID,Shen Kunwei^ORCID

Publisher

Informa UK Limited

Subject

Oncology

Reference53 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

2. Clinical and Genomic Risk to Guide the Use of Adjuvant Therapy for Breast Cancer

3. Cancer statistics, 2020

4. Early Breast Cancer Trialists’ Collaborative Group. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet. 2005;365(9472):1687–1717. doi:10.1016/S0140-6736(05)66544-0

5. Survival in patients with metastatic recurrent breast cancer after adjuvant chemotherapy

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prediction of Breast Cancer Distant Metastasis by Artificial Intelligence Methods from an Epidemiological Perspective;Istanbul Medical Journal;2022-08-01

2. Value of the 21-gene expression assay in predicting locoregional recurrence rates in estrogen receptor-positive breast cancer: a systematic review and network meta-analysis;Breast Cancer Research and Treatment;2022-04-15

3. A four-in-one pure nanomedicine for synergistic multi-target therapy against breast cancer;Journal of Materials Chemistry B;2021